Gan & Lee Pharmaceuticals. (SHA:603087)
69.20
+2.86 (4.31%)
Sep 14, 2026, 3:00 PM CST
SHA:603087 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHA:603087 stock has a consensus rating of "Strong Buy" and an average price target of ¥72.50. The average 1-year stock price forecast is 4.77% higher than the current stock price, while the lowest is ¥68.00 (-1.73%) and the highest is ¥77.00 (+11.27%).
Price Target: ¥72.50 (+4.77%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:603087 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
5.11B
from 4.05B
Increased by 26.20%
Revenue Next Year
5.75B
from 5.11B
Increased by 12.53%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.